ClinicalTrials.Veeva

Menu

Using Spectrally Encoded Confocal Microscopy (SECM) to Image the Esophagus

Mass General Brigham logo

Mass General Brigham

Status

Active, not recruiting

Conditions

Eosinophilic Esophagitis

Treatments

Device: SECM Capsule

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT02202590
5R01DK091923-03 (U.S. NIH Grant/Contract)
2013-P000863

Details and patient eligibility

About

The goal of this study is to test the feasibility and the tolerability of a tethered spectrally encoded confocal microscopy (SECM) capsule and to use it to image the esophagus.

Full description

96 participants including healthy volunteers, patients with a suspicion of having Eosinophilic Esophagitis (EoE) and patients with a current or prior clinical diagnosis of EoE will be recruited and asked to swallow the SECM capsule while being awake and unsedated. The capsule is attached to a tether which allows the operator to control as well as navigate the capsule as it progresses down the esophagus using natural propulsive force called peristalsis.

As the capsule progresses, multiple 2-dimensional cross-sectional images of the esophagus are acquired. Images are analyzed at a later stage.

Enrollment

96 estimated patients

Sex

All

Ages

14+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Participant must be a healthy volunteer
  • OR participant must have a suspicion of EoE
  • OR participant must have a prior clinical suspicion of EoE
  • Participant must be older than 14 years of age
  • Participant must be able to give informed consent

Exclusion criteria

  • Participants with the inability to swallow pills and capsules.
  • Esophageal fistula and/or esophageal strictures with a stricture diameter that is smaller than the diameter of the capsule.
  • Participants with prior endoscopic ablation or resection treatment of Barrett's Esophagus (BE)

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

96 participants in 1 patient group

Imaging
Experimental group
Description:
Participant will swallow the SECM capsule and Imaging will be performed using the SECM Imaging system.
Treatment:
Device: SECM Capsule

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems